National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody MDX-060
A monoclonal antibody with potential antineoplastic activity. MDX-060 is a fully humanized antibody that targets CD30, a member of the tumor necrosis factor receptor superfamily found on activated lymphocytes. CD30 is over-expressed in various lymphoproliferative disorders, Hodgkin's disease and other lymphomas, and other cancers. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:MDX-060



Previous:monoclonal antibody HuPAM4, monoclonal antibody KW-2871, monoclonal antibody L6, monoclonal antibody Lym-1, monoclonal antibody m170
Next:monoclonal antibody Me1-14 F(ab')2, monoclonal antibody Mik-beta-1, monoclonal antibody R24, monoclonal antibody RAV12, monoclonal antibody SGN-30

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov